![]() MES hydrate structure
|
Common Name | MES hydrate | ||
---|---|---|---|---|
CAS Number | 1266615-59-1 | Molecular Weight | 213.252 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C6H15NO5S | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Name | 2-(4-morpholinyl)ethanesulfonic acid hydrate |
---|---|
Synonym | More Synonyms |
Molecular Formula | C6H15NO5S |
---|---|
Molecular Weight | 213.252 |
Exact Mass | 213.067093 |
Personal Protective Equipment | Eyeshields;Gloves |
---|---|
RIDADR | NONH for all modes of transport |
A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.
Oncotarget 6 , 39276-91, (2015) ATP-binding cassette subfamily G member 2 (ABCG2) is a member of the ABC transporter superfamily proteins, which has been implicated in the development of multidrug resistance (MDR) in cancer, apart f... |
|
Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.
Biochem. Pharmacol. 90(4) , 367-78, (2014) Cancer cells often become resistant to chemotherapy through a phenomenon known as multidrug resistance (MDR). Several factors are responsible for the development of MDR, preeminent among them being th... |
|
Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation.
Mol. Pharm. 11(7) , 2334-45, (2014) Curcumin has potent antioxidant and anti-inflammatory properties but poor absorption following oral administration owing to its low aqueous solubility. Development of novel formulations to improve its... |
2-(4-Morpholinyl)ethanesulfonic acid hydrate (1:1) |
4-Morpholineethanesulfonic acid, hydrate (1:1) |
2-(4-morpholinyl)ethanesulfonic acid hydrate |
2-(Morpholin-4-yl)ethanesulfonic acid hydrate (1:1) |
EINECS 224-632-3 |